International Edition
Latest News
Health

AI and Interval Breast Cancer: What Leading Radiologists Say About the Lancet Study

Here's a breakdown of the cautions readers should consider when assessing the study results, based on the provided text from the interviews with the doctors: 1. Generalizability - Differences in Reading Practices: * Single vs. Double Reading: A…

AI and Interval Breast Cancer: What Leading Radiologists Say About the Lancet Study

Here’s a breakdown of the cautions readers should consider when assessing the study results, based on the provided text from the interviews with the doctors:

1. Generalizability – Differences in Reading Practices:

* Single vs. Double Reading: A major concern is that the Swedish study was conducted in a system with double reading (two radiologists independently review each mammogram). The US typically uses single reading. Dr. Patel specifically calls this into question,stating more US-based studies with single readers are needed. this substantially impacts how the AI’s performance translates to the US healthcare system.
* Swedish Context: The study was done in Sweden, and healthcare systems and patient populations can vary significantly between countries.This limits how broadly the results can be applied.

2. Limited Timeframe & Long-term Effects:

* Short Study Duration: the study only covered a 20-month period (Dr. Destounis). We don’t know the long-term impact of AI on:
* Interval Cancer Detection: Whether AI will continue to reduce the rate of cancers found between scheduled screenings.
* Cancer Type: Whether the types of invasive cancers detected will change over time.
* Sustained Benefits: Whether the initial positive effects of AI will persist in subsequent screening rounds.
* One Round of Screening: The study only evaluated one round of screening, making it unclear if the benefits will be sustained. (Dr. Berg)

3. Implementation & Cost:

* Lack of Reimbursement: Currently, there’s no financial reimbursement for implementing AI in mammography (Dr. Berg). This creates a barrier to adoption by healthcare systems.
* Radiologist Oversight: The doctors agree that AI interpretation shouldn’t be done without oversight by a radiologist, at least not yet. (Dr. Berg)

4. Radiologist Experience & data Diversity:

* Radiologist Skill Level: Dr.Patel points out that the study’s results might vary depending on the experience level of the radiologists using the system. Less experienced readers might see different outcomes.
* Data Diversity: The diversity of the data used to train and test the AI is vital. Variability in outcomes with radiologists who are less experienced readers would be other factors to take into consideration. (Dr. Patel)

In essence, while the study is promising, readers should be cautious about assuming the same results will be seen in the US, and thay should await longer-term data to confirm the benefits and understand potential drawbacks.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”